Clinical Trials
22 trialsNCT04994132 2026-05-05
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
Children's Oncology Group
Phase 3 Active not recruiting
NCT07466316 2026-03-12
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Children's Oncology Group
Phase 3 Not yet recruiting
NCT03443128 2025-02-13
Vinorelbine for Recurrent ALCL-2017
Children's Cancer Group, China
Phase 2 Completed
NCT02954055 2024-02-26
METEORA-II
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT00005847 2023-06-22
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT03397953 2022-07-26
Vinorelbine for Recurrent ACLC
Children's Cancer Group, China
Phase 2 Completed
NCT01026220 2022-04-28
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
Children's Oncology Group
Phase 3 Completed
NCT00302003 2021-03-30
Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
Children's Oncology Group
Phase 3 Completed
NCT00002583 2020-04-03
Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
Canadian Cancer Trials Group
Phase 3 Completed
NCT00064077 2018-10-17
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
GOG Foundation
Phase 3 Completed
NCT00003234 2014-07-28
Vinorelbine in Treating Children With Recurrent or Refractory Cancers
Children's Oncology Group
Phase 2 Completed
NCT00006760 2013-07-26
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
Children's Oncology Group
Phase 2 Completed
NCT00070304 2013-07-26
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
Children's Oncology Group
Phase 2 Completed
NCT00041067 2013-06-06
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00002813 2013-05-27
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00026156 2013-02-15
S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00015938 2013-01-24
S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00003587 2012-10-08
S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00003828 2012-08-22
S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
SWOG Cancer Research Network
Phase 2 Completed
NCT00049660 2012-07-18
Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Terminated
NCT00003730 2012-07-02
Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase NA Completed
NCT00737867 2011-04-04
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
The Norwegian Lung Cancer Study Group
Phase 3 Completed